GE HealthCare Technologies Inc. director Kevin Lobo has purchased 10,000 shares of the company's common stock at $64.18 per share through an open-market transaction. Following this purchase, Lobo directly owns a total of 14,363 shares of GE HealthCare. This insider activity indicates positive sentiment and has been categorized as having a high filing impact.

Delta Air Lines Inc (DAL) shares surged 4.3%, reaching $79.39, but are considered significantly overvalued with a GF Value of $54.09. Despite a strong GF Score of 83/100, driven by profitability and momentum, the stock's valuation and recent insider selling of $14.3 million flag caution for investors.

UBS analyst Michael Goldsmith raised the price target for Extra Space Storage Inc. (EXR) to $158 from $148 while reiterating a Buy rating. The company's Q1 2026 earnings showed core FFO at $2.04 per share, up 2%, and same-store revenue growth of 1.7%, with future acquisition plans totaling around $200 million for 2026. This positive outlook is supported by improving revenue trends and increasing new customer rates.

Weyerhaeuser Company Limited was convicted last week and fined $355,000 under Alberta's Occupational Health and Safety Act following the death of a sawmill worker in Grande Prairie in 2023. The company pleaded guilty to failing to ensure worker health and safety, and the funds will be used by Northwestern Polytechnic to develop a comprehensive safety training program for inexperienced workers in various industries. This initiative aims to prevent future incidents and empower employees to refuse unsafe work.

Caterpillar Inc. stock climbed 5% this week, driven by strong Q1 earnings, positive analyst sentiment, and a growing Power & Energy segment linked to AI data centers. The company is increasingly seen as a power infrastructure leader, with its engines and generators supporting energy-intensive markets. Analysts have raised price targets, and a valuation model suggests the stock is modestly undervalued with potential for 18% upside, assuming strong revenue growth and healthy margins sustained by its diverse market demand.

Exxon Mobil Corp. and ConocoPhillips are in active negotiations with the Venezuelan government to re-enter the country's oil sector after a two-decade absence. Both companies are pushing for robust contract terms and a mechanism to resolve billions in owed compensation, seeking safeguards against future nationalization. Their potential return, driven by political will from both Venezuela and the U.S., represents a significant opportunity to tap Venezuela's vast oil reserves and signal economic stability.

Barclays has maintained an "Overweight" rating for CVS Health (CVS) and raised its price target from $101.00 to $106.00, suggesting a potential 4.95% increase from its current market performance. Despite this positive analyst outlook, GuruFocus indicates CVS is currently 17.4% overvalued with a GF Value™ of $77.69 against its price of $91.23, and shows significant insider selling activity totaling $323.7 million over the past three months. Investors are advised to consider both the strong analyst endorsements and the valuation metrics, alongside insider selling, when evaluating CVS Health.

Merck (NYSE: MRK) has announced that its Board of Directors declared a quarterly dividend of $0.85 per share of common stock for the third quarter of 2026. This payment is scheduled for July 8, 2026, to shareholders of record as of June 15, 2026. The company also included a forward-looking statement regarding potential risks and uncertainties that could affect future results.

FMC Corporation announced that its CFO, Andrew Sandifer, will speak at the 16th Annual Wells Fargo Industrials & Materials Conference on June 9, 2026, at 2:15 p.m. Central Time. A live webcast of his presentation will be available for investors. FMC is a global agricultural sciences company providing innovative crop protection solutions to growers.

Gartner warns that the rush to agentic AI in supply chain planning (SCP) organizations carries risks of hype and "agent washing." Most current agentic capabilities improve user experience rather than fundamentally changing decision quality, and true end-to-end autonomous planning is not expected before 2027. SCP leaders should prioritize building operational discipline and flexible frameworks, and avoid common missteps like mistaking vendor positioning for true autonomy or pursuing high-risk autonomous use cases too early.